Managing Medicare's HIV caseload in the era of suppressive therapy.

OBJECTIVES: The 1996 introduction of antiretroviral medications changed Medicare's role in providing HIV care. We analyzed Medicare's patient database in an effort to document the new HIV therapies' effects on expenditures and outcomes. METHODS: We examined the medical billing records of a 5% nation...

Full description

Bibliographic Details
Published in:American Journal of Public Health Vol. 97; no. 6; pp. 1053 - 1060
Main Authors: Gilden DE, Kubisiak JM, Gilden DM
Format: research tables/charts Journal Article
Published: American Public Health Association Jun2007
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106123416&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106123416
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00900036
        APH
      jtl: American Journal of Public Health
      issn: 00900036
      maglogo: N
    pubinfo:
      dt: Jun2007
      vid: 97
      iid: 6
      pid: 44
      pub: American Public Health Association
      place: Washington, District of Columbia
    artinfo:
      ui:
        106123416
        25302434
        2009602034
        10.2105/AJPH.2005.063636
        NLM17463389
        106123416
      ppf: 1053
      ppct: 7
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Managing Medicare's HIV caseload in the era of suppressive therapy.
      aug:
        au:
          Gilden DE
          Kubisiak JM
          Gilden DM
        affil: JEN Associates Inc, Cambridge, Mass 02139, USA.
      sug:
        subj:
          Antiretroviral Therapy, Highly Active Economics
          Anti-HIV Agents
          Medicare Economics
          Adult
          Black Persons
          Chronic Disease
          Persons with Disabilities
          Female
          Hispanic Americans
          HIV Infections Ethnology
          HIV Infections Mortality
          Male
          Middle Age
          Mortality
          Odds Ratio
          Regression
          United States
          White Persons
          Human
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Female
          Male
      ab: OBJECTIVES: The 1996 introduction of antiretroviral medications changed Medicare's role in providing HIV care. We analyzed Medicare's patient database in an effort to document the new HIV therapies' effects on expenditures and outcomes. METHODS: We examined the medical billing records of a 5% national Medicare sample from 1997 through 2003. The cohort was stratified by year and categorized by age, race/ethnicity, gender, and Medicare status. Population summaries were categorized according to presence of major chronic diseases and HIV-related conditions. RESULTS: The number of Medicare beneficiaries with HIV increased from 42520 in 1997 to 76500 in 2003, whereas mortality among this group fell by 35%. HIV-associated infections declined by as much as 43% (mycoses). Heart and liver disease and diabetes increased by more than 50%. Adjusted annual per person Medicare expenditures fell 28%; expenditures were 49% higher for Blacks than for Whites. CONCLUSIONS: Improved HIV medical management has led to fewer deaths and has shifted treatment toward chronic care. However, successful management is complicated by conditions that have not been historically linked to HIV and whose effects vary according to race/ethnicity.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N